Central Parkin: The evolving role of Parkin in the heart

Biochimica et Biophysica Acta - Bioenergetics

Volumn 1857, Issue 8, 2016, Pages 1307-1312

  Dorn, Gerald W ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PARKIN; DNM1L PROTEIN, MOUSE; DYNAMIN; GUANOSINE TRIPHOSPHATASE; MFN2 PROTEIN, HUMAN; MITOCHONDRIAL PROTEIN; PROTEIN KINASE; PTEN-INDUCED PUTATIVE KINASE; UBIQUITIN PROTEIN LIGASE;

ARTICLE; CARDIAC MUSCLE CELL; CELL REPROGRAMMING TECHNIQUE; HEART MITOCHONDRION; HEART STRESS; HOMEOSTASIS; INTRACELLULAR SIGNALING; MITOPHAGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; TURNOVER TIME; ANIMAL; CARDIAC MUSCLE; DEFICIENCY; DISEASE MODEL; DROSOPHILA MELANOGASTER; GENE EXPRESSION REGULATION; GENETICS; HEART INFARCTION; HUMAN; KNOCKOUT MOUSE; METABOLISM; MOUSE; PARKINSON DISEASE; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; DISEASE MODELS, ANIMAL; DROSOPHILA MELANOGASTER; DYNAMINS; GENE EXPRESSION REGULATION; GTP PHOSPHOHYDROLASES; HUMANS; MICE; MICE, KNOCKOUT; MITOCHONDRIA, HEART; MITOCHONDRIAL DEGRADATION; MITOCHONDRIAL PROTEINS; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; PARKINSON DISEASE; PROTEIN KINASES; SIGNAL TRANSDUCTION; UBIQUITIN-PROTEIN LIGASES;

EID: 84961786611     PISSN: 00052728     EISSN: 18792650     Source Type: Journal    
DOI: 10.1016/j.bbabio.2016.03.014     Document Type: Article

References (62)

1. [1] Shulman, J.M., De Jager, P.L., Feany, M.B., Parkinson's disease: genetics and pathogenesis. Annu. Rev. Pathol. 6 (2011), 193–222.
2. [2] Riley, B.E., Lougheed, J.C., Callaway, K., Velasquez, M., Brecht, E., Nguyen, L., et al. Structure and function of Parkin E3 ubiquitin ligase reveals aspects of RING and HECT ligases. Nat. Commun., 4, 2013, 1982.
3. [3] Sarraf, S.A., Raman, M., Guarani-Pereira, V., Sowa, M.E., Huttlin, E.L., Gygi, S.P., et al. Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization. Nature 496 (2013), 372–376.
4. [4] Narendra, D.P., Jin, S.M., Tanaka, A., Suen, D.F., Gautier, C.A., Shen, J., et al. PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol., 8, 2010, e1000298.
5. [5] Jin, S.M., Youle, R.J., The accumulation of misfolded proteins in the mitochondrial matrix is sensed by PINK1 to induce PARK2/Parkin-mediated mitophagy of polarized mitochondria. Autophagy 9 (2013), 1750–1757.
6. [6] Chen, Y., Dorn, G.W. 2nd, PINK1-phosphorylated mitofusin 2 is a Parkin receptor for culling damaged mitochondria. Science 340 (2013), 471–475.
7. [7] Gong, G., Song, M., Kelly, D.P., Matkovich, S.J., Dorn, G.W. 2nd, Parkin-mediated mitophagy directs perinatal cardiac metabolic maturation in mice. Science, 350, 2015 (aad2459).
8. [8] Koyano, F., Okatsu, K., Kosako, H., Tamura, Y., Go, E., Kimura, M., et al. Ubiquitin is phosphorylated by PINK1 to activate parkin. Nature 510 (2014), 162–166.
9. [9] Kane, L.A., Lazarou, M., Fogel, A.I., Li, Y., Yamano, K., Sarraf, S.A., et al. PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity. J. Cell Biol. 205 (2014), 143–153.
10. [10] Wauer, T., Simicek, M., Schubert, A., Komander, D., Mechanism of phospho-ubiquitin-induced PARKIN activation. Nature 524 (2015), 370–374.
11. [11] Lazarou, M., Sliter, D.A., Kane, L.A., Sarraf, S.A., Wang, C., Burman, J.L., et al. The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature 524 (2015), 309–314.
12. [12] Bingol, B., Tea, J.S., Phu, L., Reichelt, M., Bakalarski, C.E., Song, Q., et al. The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy. Nature 510 (2014), 370–375.
13. [13] Cornelissen, T., Haddad, D., Wauters, F., Van Humbeeck, C., Mandemakers, W., Koentjoro, B., et al. The deubiquitinase USP15 antagonizes Parkin-mediated mitochondrial ubiquitination and mitophagy. Hum. Mol. Genet. 23 (2014), 5227–5242.
14. [14] Durcan, T.M., Tang, M.Y., Perusse, J.R., Dashti, E.A., Aguileta, M.A., McLelland, G.L., et al. USP8 regulates mitophagy by removing K6-linked ubiquitin conjugates from parkin. EMBO J. 33 (2014), 2473–2491.
15. [15] Wang, Y., Serricchio, M., Jauregui, M., Shanbhag, R., Stoltz, T., Di Paolo, C.T., et al. Deubiquitinating enzymes regulate PARK2-mediated mitophagy. Autophagy 11 (2015), 595–606.
16. [16] Scarffe, L.A., Stevens, D.A., Dawson, V.L., Dawson, T.M., Parkin and PINK1: much more than mitophagy. Trends Neurosci. 37 (2014), 315–324.
17. [17] Lees, A.J., Unresolved issues relating to the shaking palsy on the celebration of James Parkinson's 250th birthday. Mov. Disord. 22:Suppl. 17 (2007), S327–S334.
18. [18] Zheng, B., Liao, Z., Locascio, J.J., Lesniak, K.A., Roderick, S.S., Watt, M.L., et al. PGC-1alpha, a potential therapeutic target for early intervention in Parkinson's disease. Sci. Transl. Med., 2, 2010 (52ra73).
19. [19] Klein, C., Westenberger, A., Genetics of Parkinson's disease. Cold Spring Harb. Perspect. Med., 2, 2012 (a008888).
20. [20] Anglade, P., Vyas, S., Javoy-Agid, F., Herrero, M.T., Michel, P.P., Marquez, J., et al. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol. Histopathol. 12 (1997), 25–31.
21. [21] Harris, H., Rubinsztein, D.C., Control of autophagy as a therapy for neurodegenerative disease. Nat. Rev. Neurol. 8 (2012), 108–117.
22. [22] Fuchs, Y., Steller, H., Live to die another way: modes of programmed cell death and the signals emanating from dying cells. Nat. Rev. Mol. Cell Biol. 16 (2015), 329–344.
23. [23] Kim, T.Y., Wang, D., Kim, A.K., Lau, E., Lin, A.J., Liem, D.A., et al. Metabolic labeling reveals proteome dynamics of mouse mitochondria. Mol. Cell. Proteomics 11 (2012), 1586–1594.
24. [24] Chan, N.C., Salazar, A.M., Pham, A.H., Sweredoski, M.J., Kolawa, N.J., Graham, R.L., et al. Broad activation of the ubiquitin-proteasome system by Parkin is critical for mitophagy. Hum. Mol. Genet. 20 (2011), 1726–1737.
25. [25] Kageyama, Y., Hoshijima, M., Seo, K., Bedja, D., Sysa-Shah, P., Andrabi, S.A., et al. Parkin-independent mitophagy requires Drp1 and maintains the integrity of mammalian heart and brain. EMBO J. 33 (2014), 2798–2813.
26. [26] Williams, J.A., Ni, H.M., Haynes, A., Manley, S., Li, Y., Jaeschke, H., et al. Chronic deletion and acute knockdown of Parkin have differential responses to acetaminophen-induced mitophagy and liver injury in mice. J. Biol. Chem. 290 (2015), 10934–10946.
27. [27] Ishihara, N., Nomura, M., Jofuku, A., Kato, H., Suzuki, S.O., Masuda, K., et al. Mitochondrial fission factor Drp1 is essential for embryonic development and synapse formation in mice. Nat. Cell Biol. 11 (2009), 958–966.
28. [28] Lee, S., Sterky, F.H., Mourier, A., Terzioglu, M., Cullheim, S., Olson, L., et al. Mitofusin 2 is necessary for striatal axonal projections of midbrain dopamine neurons. Hum. Mol. Genet. 21 (2012), 4827–4835.
29. [29] Song, M., Gong, G., Burelle, Y., Gustafsson, A.B., Kitsis, R.N., Matkovich, S.J., et al. Interdependence of Parkin-mediated mitophagy and mitochondrial fission in adult mouse hearts. Circ. Res. 117 (2015), 346–351.
30. [30] Ordureau, A., Heo, J.M., Duda, D.M., Paulo, J.A., Olszewski, J.L., Yanishevski, D., et al. Defining roles of PARKIN and ubiquitin phosphorylation by PINK1 in mitochondrial quality control using a ubiquitin replacement strategy. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 6637–6642.
31. [31] Lazarou, M., Jin, S.M., Kane, L.A., Youle, R.J., Role of PINK1 binding to the TOM complex and alternate intracellular membranes in recruitment and activation of the E3 ligase Parkin. Dev. Cell 22 (2012), 320–333.
32. [32] Chan, D.C., Fusion and fission: interlinked processes critical for mitochondrial health. Annu. Rev. Genet. 46 (2012), 265–287.
33. [33] de Brito, O.M., Scorrano, L., Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature 456 (2008), 605–610.
34. [34] Chen, Y., Csordas, G., Jowdy, C., Schneider, T.G., Csordas, N., Wang, W., et al. Mitofusin 2-containing mitochondrial-reticular microdomains direct rapid cardiomyocyte bioenergetic responses via interorganelle Ca(2 +) crosstalk. Circ. Res. 111 (2012), 863–875.
35. [35] Becker, K.D., Gottshall, K.R., Chien, K.R., Strategies for studying cardiovascular phenotypes in genetically manipulated mice. Hypertension 27 (1996), 495–501.
36. [36] Greene, J.C., Whitworth, A.J., Kuo, I., Andrews, L.A., Feany, M.B., Pallanck, L.J., Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc. Natl. Acad. Sci. U. S. A. 100 (2003), 4078–4083.
37. [37] Clark, I.E., Dodson, M.W., Jiang, C., Cao, J.H., Huh, J.R., Seol, J.H., et al. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 441 (2006), 1162–1166.
38. [38] Park, J., Lee, S.B., Lee, S., Kim, Y., Song, S., Kim, S., et al. Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 441 (2006), 1157–1161.
39. [39] Yang, Y., Gehrke, S., Imai, Y., Huang, Z., Ouyang, Y., Wang, J.W., et al. Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin. Proc. Natl. Acad. Sci. U. S. A. 103 (2006), 10793–10798.
40. [40] Vincow, E.S., Merrihew, G., Thomas, R.E., Shulman, N.J., Beyer, R.P., MacCoss, M.J., et al. The PINK1-Parkin pathway promotes both mitophagy and selective respiratory chain turnover in vivo. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 6400–6405.
41. [41] Guo, M., Drosophila as a model to study mitochondrial dysfunction in Parkinson's disease, Cold Spring Harb. Perspect. Med., 2(11), 2012 (009944).
42. [42] Lee, Y., Dawson, V.L., Dawson, T.M., Animal models of Parkinson's disease: vertebrate genetics, Cold Spring Harb. Perspect. Med., 2(10), 2012 (009324).
43. [43] Winklhofer, K.F., Haass, C., Mitochondrial dysfunction in Parkinson's disease. Biochim. Biophys. Acta 1802 (2010), 29–44.
44. [44] Bhandari, P., Song, M., Chen, Y., Burelle, Y., Dorn, G.W. 2nd, Mitochondrial contagion induced by Parkin deficiency in Drosophila hearts and its containment by suppressing mitofusin. Circ. Res. 114 (2014), 257–265.
45. [45] Song, M., Matkovich, S.J., Zhang, Y., Hammer, D.J., Dorn, G.W. 2nd, Combined cardiomyocyte PKCdelta and PKCepsilon gene deletion uncovers their central role in restraining developmental and reactive heart growth. Sci. Signal., 8, 2015, ra39.
46. [46] Kubli, D.A., Zhang, X., Lee, Y., Hanna, R.A., Quinsay, M.N., Nguyen, C.K., et al. Parkin protein deficiency exacerbates cardiac injury and reduces survival following myocardial infarction. J. Biol. Chem. 288 (2013), 915–926.
47. [47] Shin, J.H., Ko, H.S., Kang, H., Lee, Y., Lee, Y.I., Pletinkova, O., et al. PARIS (ZNF746) repression of PGC-1alpha contributes to neurodegeneration in Parkinson's disease. Cell 144 (2011), 689–702.
48. [48] Stevens, D.A., Lee, Y., Kang, H.C., Lee, B.D., Lee, Y.I., Bower, A., et al. Parkin loss leads to PARIS-dependent declines in mitochondrial mass and respiration. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 11696–11701.
49. [49] Kubli, D.A., Quinsay, M.N., Gustafsson, A.B., Parkin deficiency results in accumulation of abnormal mitochondria in aging myocytes. Commun. Integr. Biol., 6, 2013, e24511.
50. [50] Dorn, G.W. 2nd, Mitochondrial dynamics in heart disease. Biochim. Biophys. Acta 1833 (2013), 233–241.
51. [51] Dorn, G.W. 2nd, Parkin-dependent mitophagy in the heart. J. Mol. Cell. Cardiol., S0022-2828(15), 2015 (30127-9 [Epub ahead of print]).
52. [52] Kubli, D.A., Cortez, M.Q., Moyzis, A.G., Najor, R.H., Lee, Y., Gustafsson, A.B., PINK1 is dispensable for mitochondrial recruitment of parkin and activation of mitophagy in cardiac myocytes. PLoS One, 10, 2015, e0130707.
53. [53] Song, M., Mihara, K., Chen, Y., Scorrano, L., Dorn, G.W. 2nd, Mitochondrial fission and fusion factors reciprocally orchestrate mitophagic culling in mouse hearts and cultured fibroblasts. Cell Metab. 21 (2015), 273–285.
54. [54] Chen, Y., Sparks, M., Bhandari, P., Matkovich, S.J., Dorn, G.W. 2nd, Mitochondrial genome linearization is a causative factor for cardiomyopathy in mice and Drosophila. Antioxid. Redox Signal. 21 (2014), 1949–1959.
55. [55] Song, M., Chen, Y., Gong, G., Murphy, E., Rabinovitch, P.S., Dorn, G.W. 2nd, Super-suppression of mitochondrial reactive oxygen species signaling impairs compensatory autophagy in primary mitophagic cardiomyopathy. Circ. Res. 115 (2014), 348–353.
56. [56] Dai, D.F., Johnson, S.C., Villarin, J.J., Chin, M.T., Nieves-Cintron, M., Chen, T., et al. Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure. Circ. Res. 108 (2011), 837–846.
57. [57] Ding, W.X., Ni, H.M., Li, M., Liao, Y., Chen, X., Stolz, D.B., et al. Nix is critical to two distinct phases of mitophagy, reactive oxygen species-mediated autophagy induction and Parkin-ubiquitin-p62-mediated mitochondrial priming. J. Biol. Chem. 285 (2010), 27879–27890.
58. [58] Dorn, G.W. 2nd, Mitochondrial pruning by Nix and BNip3: an essential function for cardiac-expressed death factors. J. Cardiovasc. Transl. Res. 3 (2010), 374–383.
59. [59] Stanley, W.C., Recchia, F.A., Lopaschuk, G.D., Myocardial substrate metabolism in the normal and failing heart. Physiol. Rev. 85 (2005), 1093–1129.
60. [60] Bartelds, B., Knoester, H., Smid, G.B., Takens, J., Visser, G.H., Penninga, L., et al. Perinatal changes in myocardial metabolism in lambs. Circulation 102 (2000), 926–931.
61. [61] Dorn, G.W. 2nd, Vega, R.B., Kelly, D.P., Mitochondrial biogenesis and dynamics in the developing and diseased heart. Genes Dev. 29 (2015), 1981–1991.
62. [62] Taegtmeyer, H., Sen, S., Vela, D., Return to the fetal gene program: a suggested metabolic link to gene expression in the heart. Ann. N. Y. Acad. Sci. 1188 (2010), 191–198.